| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |